CD8A and neoplasm: Experimental evidence suggests that tumor-infiltrating cDC1s promote tumor control in various ways, including the production of chemokines such as C-X-C motif chemokine ligand 9 (CXCL9) and C-X-C motif chemokine ligand 10 (CXCL10), which recruit CD8+ T cells to the tumor site.